Medicine : Biomyf (250mg)

Name:Biomyf (250mg)
Type:Tablet
Manufacturer:Bioniche Life Sciences Inc
Generic Use:Mycophenolate Moftil
Composition:Mycophenolate Moftil(250 Mg)
Substitutes:mtcofit (250mg) , mycophen (250mg) , mycofit (250mg) , renofix m(250mg) , renodapt (250mg) , mofetyl (250mg) , baxmune (250mg) , mycept (250mg) , mofilet (250mg) , cellcept (250mg) , biomyf (250mg)


Generic ( Mycophenolate Moftil )



Typical use Of Mycophenolate Moftil :Information Not Available.
Mechanism of action of Mycophenolate Moftil :Mycophenolic Acid Acts By Blocking Purine Synthesis Of Human Lymphocytes Through Reversible Inhibition Of Inosine Monophosphate Dehydrogenase. It Also Inhibits Proliferation Of Both T- And B- Lymphocytes.
Drug Interaction of Mycophenolate Moftil :Increased Plasma Levels Of Both Drugs When Combined With aciclovir, Valaciclovir, ganciclovir and valganciclovir. Reduced Absorption Withcolestyramine, Magnesium- And aluminium hydroxide-containing Products,sevelamer and Other Calcium-free Phosphate Binders. Reduced Plasma Levels With ciclosporin, metronidazole, Quinolones, Rifamycins. May Reduce Plasma Levels Of Progestins; May Reduce Efficacy Of Oral Contraceptives. Increased Plasma Levels With Probenecid. May Reduce Efficacy Of Live Vaccines.
Side effects of Mycophenolate Moftil :Diarrhoea, Vomiting, GI Haemorrhage And Perforation; Leucopenia; Asthenia, Pain, Headache, Anaemia, Thrombocytopenia, Renal Tubular Necrosis, Haematuria, BP Changes, Hyperglycaemia, Disturbances Of Electrolytes And Blood Lipids, Peripheral Oedema, Dyspnoea, Cough, Acne, Hepatitis. Angioedema, Anaphylaxis, Fatal Pulmonary Fibrosis.

INTERACTIONS OF MYCOPHENOLATE MOFTIL


How Mycophenolate Moftil will impact on Pregnancy ?

Experiences Of Drug Use And Evidence From Studies In Pregnant Women Have Shown Risk To Fetus. This Drug May Be Used In Pregnant Women If Benefit Outweighs The Risk. Patients Should Follow The Advice Of The Doctor Regarding Its Use.

How Mycophenolate Moftil will impact during lactation(breastfeeding) ?

Possibly Unsafe: Evidence From Studies In Breastfeeding Women Show That There Is A Definite Risk Of Side Effects To The Breastfed Infants. However, Use Of The Drug In Breastfeeding Women Is Acceptable In Spite Of The Risk To The Infants, If The Drug Is Needed In A Life-threatening Situation Or For A Serious Disease For Which Safer Drugs Cannot Be Used Or Are Ineffective. Patients Should Follow The Advice Of The Doctor Regarding Its Use.

Medicine & Alcohol use and effect of Mycophenolate Moftil

No Studies Found